Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis
Crossref DOI link: https://doi.org/10.1038/s41598-019-39335-7
Published Online: 2019-02-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Makunts, Tigran
Cohen, Isaac V.
Awdishu, Linda http://orcid.org/0000-0002-3187-3264
Abagyan, Ruben
Text and Data Mining valid from 2019-02-19
Version of Record valid from 2019-02-19
Article History
Received: 22 October 2018
Accepted: 18 January 2019
First Online: 19 February 2019
Competing Interests
: The authors declare no competing interests.